Clinical data suggests tirzepatide produces slightly greater average weight loss than semaglutide, but the difference is not enormous, and some patients respond better to one medication than the other
In 2022, the market size was approximately 5.79 billion yuan, and it is expected to surge to 27.75 billion yuan by 2030
Yamazaki N, Yamanaka Y, Hashimoto Y, Shinohara Y, Shima A, Terada H: Structural features of the gene encoding human muscle type carnitine palmitoyltransferase I
Accelerates new blood vessel formation and gut-brain axis healing through growth factor modulation
Prominin-2 expression increases protrusions, decreases caveolae and inhibits Cdc42 dependent fluid phase endocytosis
How does Ozempic affect the digestive system after gallbladder removal